Physician profile
Agnes P Thomas
NPI 1700878485
$963.78
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $116 · 2021: $299 · 2022: $95.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $283.86 | 2019-2022 | |
| Lilly USA, LLC | $170.60 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $124.61 | 2019 | |
| Novo Nordisk INC | $84.09 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $48.88 | 2019 | |
| Glaxosmithkline, LLC. | $46.64 | 2020-2021 | |
| Abbvie INC. | $45.15 | 2021-2022 | |
| Esperion Therapeutics, INC. | $35.00 | 2020-2021 | |
| Pfizer INC. | $21.67 | 2021 | |
| Allergan, INC. | $19.58 | 2019 | |
| Phadia US INC. | $15.79 | 2020 | |
| Astellas Pharma US INC | $14.94 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.25 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.55 | 2021 | |
| Upsher-Smith Laboratories LLC | $12.67 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agnes Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.